Pharmaceutical manufacturer for Methylphenidate

Siegfried serves as your favored associate for comprehensive integrated pharmaceutical ingredient and drug product services with manufacturing capabilities globally. Our expertise is crucial for your venture throughout the entire lifespan. Our enthusiasm lies in creating and producing formulations. It is extraordinary for a provider of development and manufacturing services to possess such a blend of inherent technical expertise and knowledge. Pharmaceutical ingredient services entail Tailored Development and Outsourced Manufacturing for both active pharmaceutical ingredients (API) and intermediates, along with our own range of API (opiates and other regulated substances) and documentation featuring independent patented technologies. Clients utilizing our drug product services benefit from a wealth of inherited expertise in intricate oral drug delivery systems, including sterile filling, backed by in-house development, customer development and manufacturing, and a wide array of completed dosage form products. Enhancing chemical processes and formulations is our area of specialization. We collaborate closely with clients to innovate and enhance chemical processes, thus providing additional benefits and value. Siegfried operates at 11 locations globally, spanning both the Eastern and Western Hemispheres, with multi-purpose cGMP chemical manufacturing facilities in Zofingen, Switzerland; Pennsville, New Jersey, USA; Nantong, China; Minden, Germany; Saint-Vulbas, France; Evionnaz, Switzerland; and sites for manufacturing drug products in Zofingen, Switzerland; Malta; Hameln, Germany, Irvine, USA; Barberà del Vallès, Spain and El Masnou, Spain. Count on Siegfried as your preferred partner for more opportunities.

Veranova boasts over 50 years of expertise and is a frontrunner in the creation and fabrication of intricate and specialized APIs for the pharmaceutical and biotech sectors. It was previously a segment of Johnson Matthey, specializing in intricate and regulated chemical processes. The company delivers customized services throughout all phases of drug development and is split into Generics and Originators. It possesses a variety of development technologies and areas of expertise, along with a cooperative approach to API manufacturing and procedures.

Centaur Pharmaceuticals ranks among India’s few, fully integrated pharmaceutical firms with proficiencies across the pharmaceutical value chain. Centaur leverages its synergies across API, R&D, CRAM, Clinical Research and formulations to provide end-to-end solutions to prestigious pharmaceutical partners.

Harman Finochem Limited is an India-based Pharmaceutical Company catering to its clients across the globe. Established by Mr. Bhupinder Singh Manhas in 1983, our core competencies are in manufacturing and exporting of Active Pharmaceutical Ingredients mainly Metformin HCl, Fenofibrate, Divalproex Sodium, Riboflavin Phosphate Sodium, Glycopyrrolate/Glycopyrronium bromide and more.

MNK’s Specialty Generics division provides a wide variety of high-quality generic medications, focusing on pain relief, addiction treatment, and ADHD, as well as a comprehensive range of active pharmaceutical ingredients (APIs), such as acetaminophen/paracetamol, DEA scheduled compounds, and stearates. We run the largest API facility in the United States. Discover the range of excipients available from Mallinckrodt Pharmaceuticals for use in pharmaceutical drug delivery systems (DDS).

Established in 1980 by microbiologist Mr. M L N Sastry, Malladi Drugs & Pharmaceuticals Ltd quickly emerged as a pioneer in the production of ephedrine and pseudoephedrine salts. Today, it holds a prominent position as a manufacturer of APIs in the cough and cold segment, as well as in therapeutic segments such as antihistamines, anti-convulsants, anti-depressants, and anxiolytics (CNS). With a vast export network spanning approximately 60 countries, the company derives over 85% of its revenue from international markets. Malladi's manufacturing units have received approval from prominent regulatory bodies including the FDA, EDQM, KFDA, and TGA.

ZCL Chemicals Ltd operates as a 100% Export Oriented Unit (EOU) leveraging the potential of science and technology. It was founded in 1991, with its main office located in Mumbai. The R&D Center and cGMP-manufacturing facility is situated in the industrial hub of Ankleshwar city in Gujarat, approximately 300 kilometers north of Mumbai. This strategic location is well connected by Road, Rail, and Air, facilitating efficient cargo movement to the nearest major sea/airport, which is Mumbai. The company specializes in providing a diverse range of advanced fine chemical intermediates and actives.

SCI Pharmtech Inc., founded by Switzerland-based Siegfried Ltd. in 1987, is now a public company listed at Taiwan Stock Exchange.Since 1989, SCI has satisfied worldwide customers with quality and cost- effective APIs, advanced intermediates, and custom products.Our fully equipped research laboratories, pilot and production plants and experienced staff ensure timely development and cost effective production. We work with pharmaceutical and specialty companies worldwide to develop key intermediates, APIs and custom products. Our facility is FDA,EDQM,PMDA and Taiwan TFDA inspected, designed for multi-purpose, full-scale manufacturing.

Amarin Technologies S.A. (Amarin) operates as a well-established Argentinean company located in Buenos Aires, Argentina, focusing specifically on the development of topical and transdermal pharmaceutical products through the utilization of proprietary drug delivery technologies and expertise. The R&D team of Amarin has been active since the early 1986 and has successfully brought innovative formulations and generic versions of well-established drugs to various markets worldwide, including EU, Latam and the US (Fentanyl, Rivastigmine, Buprenorphine, and Diclofenac). Helm AG, a Hamburg-based company, became a strategic shareholder in Amarin in September 2010.

Labomed S.A. is a Greek privately owned contract development and manufacturing organization (CDMO), resulting from the fusion of LaboServe S.A. and Documed Limited. Focused on comprehensive services for Generic and Value-Added medications in the form of oral liquid, Labomed has amassed substantial expertise, intellectual property rights, and projects aimed at commercialization in Europe and the US. The company's manufacturing facilities, which are approved by the European Union Good Manufacturing Practice (EU-GMP), are based in Athens, Greece, and are backed by strong quality control systems and a team of specialists and highly skilled personnel. It is this blend of knowledge and infrastructure that sets Labomed apart.